# Exert Therapeutics (Exert Therapeutics Limited)

Private limited company registered in London, classed under “Research and experimental development on biotechnology”.

- Company number: 14924663
- Status: Active
- Type: Private limited company
- Incorporated: 8 June 2023
- Registered office: Crown House, 27 Old Gloucester Street, London, WC1N 3AX
- Location: London
- Activity: Research and experimental development on biotechnology

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Exert Therapeutics do?

Private limited company registered in London, classed under “Research and experimental development on biotechnology”.

### How much turnover does Exert Therapeutics make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/exert-therapeutics-14924663

### Is Exert Therapeutics profitable?

Exert Therapeutics's profit isn't public: small companies may file without a profit and loss account.

### How many people work at Exert Therapeutics?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/exert-therapeutics-14924663

### Who runs and owns Exert Therapeutics?

Its directors are David Boothe. Its owners are shown to subscribers.

### Where is Exert Therapeutics based?

Its registered office is Crown House, 27 Old Gloucester Street, London, WC1N 3AX, in London.

### When was Exert Therapeutics founded?

Exert Therapeutics Limited was incorporated on 8 June 2023.

### Is Exert Therapeutics still trading?

The register lists Exert Therapeutics Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-04-24: Accounts for a dormant company made up to 30 June 2025
- 2025-03-07: Micro company accounts made up to 30 June 2024
- 2024-08-31: Compulsory strike-off action has been discontinued
- 2024-08-27: First Gazette notice for compulsory strike-off
- 2023-09-26: Sub-division of shares on 1 September 2023
- 2023-09-26: Resolutions
- 2023-09-21: Notification of William Hariri as a person with significant control on 1 September 2023
- 2023-09-18: Change of details for Mr David Boothe as a person with significant control on 1 September 2023
- 2023-09-18: Statement of capital following an allotment of shares on 1 September 2023 · GBP 1,000
- 2023-06-08: Incorporation

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/exert-therapeutics-14924663